News
Pharma major Cipla will release its Q4 FY25 earnings on May 13, 2025. The Board may also consider a final dividend for FY25.
The second executive at a drugmaker said his company was "stockpiling" in the United States, the pharma industry's biggest ...
Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...
US President Donald Trump’s sudden, shocking 90-day pause on his so-called “reciprocal” tariffs (they were not reciprocal) ...
14h
Clinical Trials Arena on MSNMaaT Pharma reports safety interim analysis from trial of microbiome therapyFrench biotechnology company MaaT Pharma has reported positive results from an interim safety analysis of its Phase IIb ...
Russia's president Vladimir Putin has appointed a little known company to manage assets linked to major German pharmaceutical ...
The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...
Is Pfizer a biotech or pharma company? Pfizer is typically viewed as a pharma company because of its large size. However, it also develops and markets biologics as biotech companies do.
In this week’s edition of InnovationRx, we look at the impact of tariffs on healthcare costs, pioneers of treating MS, AI for ...
While Donald Trump spared pharma companies from his tariff announcement last week, he revealed yesterday plans to announce ...
NewAmsterdam Pharma Company N.V.’s NAMS share price has dipped by 12.17%, which has investors questioning if this is right time to buy.
In the latest in a growing trend of pharma reshuffling moves in Asia, Marubeni Corporation is absorbing Sumitomo Pharma’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results